Biden's Stage Four Cancer Diagnosis: Aggressive, But Hormone-Sensitive

Former President Joe Biden's prostate cancer diagnosis has been confirmed as stage four, according to a statement released by his personal office on May 18, 2025. The statement detailed that the cancer has metastasized to the bone and is characterized by a Gleason score of 9 and Grade Group 5, indicating an aggressive form of the disease. While the news is concerning, there is some hope as the cancer appears to be hormone-sensitive, potentially allowing for effective management. The video analysis also points out that survival rates for stage four prostate cancer that has spread beyond the pelvis can be as low as 30% over five years. However, the hormone-sensitive nature of the cancer offers a more positive outlook for treatment options. This news underscores the importance of regular health checkups and early detection in managing serious illnesses.